Abstract. adriamycin (adM) is a drug used in the treatment of various types of cancer and exerts an antineoplastic effect mainly through the induction of apoptosis. Phosphoinositide 3 kinase (Pi3K)/akt and MaPK are fundamental survival pathways activated by exposure to most chemotherapeutical agents. However, the role of these pathways in the adM-induced apoptosis of leukemia cells remains unclear. in the present study, adM triggered dose-dependent cytotoxicity and resulted in a significant loss of cell viability in HL-60 cells. Moreover, treatment with ADM significantly reduced mitochondrial membrane potential (ΔΨ m ) in the cells. akt and erK activation was also detected, and the inhibition of these two pathways resulted in the enhancement of adM-induced apoptosis. These results indicate that the Pi3K/akt and erK survival pathways antagonize the chemotherapeutic effect of adM. Thus, inhibiting these pathways may serve to enhance the effect of adM.